Clinical evidence: Stable chronic obstructive pulmonary disease

作者: H. A M Kerstjens

DOI: 10.1136/BMJ.319.7208.495

关键词:

摘要: This review is taken from Issue 1 of Clinical Evidence , a new information resource for clinicians published by BMJ Publishing Group. The compendium will be updated and expanded every six months. Future issues cover respiratory stimulants, DNAse, α1 antitrypsin augmentation, vaccination against influenza streptococcus. #### Key messages Definition: Chronic obstructive pulmonary disease (COPD) characterised airflow obstruction caused chronic bronchitis, emphysema, or both Emphysema defined as abnormal permanent enlargement the air spaces distal to terminal bronchioles, accompanied destruction their walls without obvious fibrosis. bronchitis cough, mucus production, both, at least three months two successive years where other …

参考文章(32)
P. M. A. Calverley, Symptomatic Bronchodilator Treatment Springer US. pp. 419- 445 ,(1995) , 10.1007/978-1-4899-4525-9_17
Wright Ec, Anthonisen Nr, Bronchodilator response in chronic obstructive pulmonary disease. The American review of respiratory disease. ,vol. 133, pp. 814- 819 ,(1986)
N.M. Siafakas, P. Vermeire, N.B. Pride, P. Paoletti, J. Gibson, P. Howard, J.C. Yernault, M. Decramer, T. Higenbottam, D.S. Postma, J. Rees, Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force European Respiratory Journal. ,vol. 8, pp. 1398- 1420 ,(1995) , 10.1183/09031936.95.08081398
A. Grove, B. J. Lipworth, P. Reid, R. P. Smith, L. Ramage, C. G. Ingram, R. J. Jenkins, J. H. Winter, D. P. Dhillon, Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Thorax. ,vol. 51, pp. 689- 693 ,(1996) , 10.1136/THX.51.7.689
M.G. Matera, M. Cazzola, A. Vinciguerra, F. Di Perna, F. Calderaro, M. Caputi, F. Rossi, A comparison of the bronchodilating effects of salmeterol, salbutamol and Ipratropium bromide in patients with chronic obstructive pulmonary disease Pulmonary Pharmacology. ,vol. 8, pp. 267- 271 ,(1995) , 10.1006/PULP.1995.1036
David C. Levin, Katherine S. Little, Kathryn R. Laughlin, J. Mark Galbraith, Paul M. Gustman, Debbie Murphy, Jerrold A. Kram, Grace Hardie, Cindy Reuter, David Ostransky, Karen McFarland, Thomas L. Petty, Wayne Silvers, Stephen I. Rennard, Mary Mueller, Lawrence H. Repsher, Richard L. Zuwallack, Rick Vale, Addition of anticholinergic solution prolongs bronchodilator effect of β2agonists in patients with chronic obstructive pulmonary disease The American Journal of Medicine. ,vol. 100, ,(1996) , 10.1016/S0002-9343(96)80073-8
Chang S. Shim, M.Henry Williams, Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease. The American Journal of Medicine. ,vol. 78, pp. 655- 658 ,(1985) , 10.1016/0002-9343(85)90409-7
Christopher M. Callahan, Oral Corticosteroid Therapy for Patients with Stable Chronic Obstructive Pulmonary Disease Annals of Internal Medicine. ,vol. 114, pp. 216- 223 ,(1991) , 10.7326/0003-4819-114-3-216